0.00
Finanzdaten der Vaxxinity Inc-Aktie (VAXX)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums | 2023-09-30 | 2023-06-30 | 2023-03-31 |
Periodenlänge | 3 Monate | 3 Monate | 3 Monate |
Revenues |
-
|
- | - |
|
6.81%
13.45
|
14.43 | 18.81 |
Interest Income/Expense |
20.55%
0.176
|
0.146 | 0.192 |
Operating Income/Loss |
6.81%
-13.45
|
-14.43 | -18.81 |
Income/Loss From Continuing Operations Before Tax |
5.95%
-13.14
|
-13.98 | -18.42 |
Income/Loss From Continuing Operations After Tax |
5.95%
-13.14
|
-13.98 | -18.42 |
|
5.95%
-13.14
|
-13.98 | -18.42 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - |
Attributable To Noncontrolling Interest |
-
|
- | - |
Basic Average Shares |
0.20%
126.74
|
126.48 | 126.06 |
Diluted Average Shares |
0.20%
126.74
|
126.48 | 126.06 |
Basic Earnings Per Share |
9.09%
-0.10
|
-0.11 | -0.15 |
Diluted Earnings Per Share |
9.09%
-0.10
|
-0.11 | -0.15 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - |
Kapitalisierung:
|
Volumen (24h):